SSII NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

SS Innovations International Inc. Common Stock · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 3.98 USD
14.5% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -6.9% below the Trend Line and sits at 12.6% of its 52-week range. The latest completed week returned 14.5%, after a 5.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 62/100. Near-term considerations: earnings are due in 4d.

Setup score 32 out of 100
Latest Close 3.98 USD 31 Jul 2026
1W Return 14.5% latest completed week
4W Return 5.3% short-term follow-through
12W Return 2.8% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.6x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 37.80% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 14.5% Latest completed week; four-week move 5.3%. Indicator stack 0/69 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 37.80% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 62/100 52 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -6.9% below the Trend Line and sits at 12.6% of its 52-week range. The latest completed week returned 14.5%, after a 5.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0312-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 5.3% over four weeks, 2.8% over 12 weeks, and -35.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W14.5%
4W5.3%
12W2.8%
26W-5.9%
52W-35.8%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.37Latest activity-pressure read.
Pressure change150.1%Four-week change in activity pressure.
Leadership-32.29Latest relative-leadership reading.
RS change21.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength1/100Blend of value, momentum, and quality. Underlying universe rank 100; rank 1 is best.
Value14/100Relative valuation strength. Underlying universe rank 87; rank 1 is best.
Quality4/100Profitability and accounting quality. Underlying universe rank 97; rank 1 is best.
Momentum5/100Medium-term price momentum. Underlying universe rank 96; rank 1 is best.
Growth89/100Revenue and earnings growth. Underlying universe rank 12; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
14.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-1.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
48.4%
Gross profit retained from each unit of revenue.
Operating margin
-10.1%
Operating profit retained from revenue.
Free-cash-flow margin
-24.6%
Free cash flow generated from revenue.
Return on invested capital
-7.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
148.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment62/100

Weighted news tone is positive across 52 relevant articles.

23 positive · 28 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-60.2%Distance below the 52-week high.
13-week volatility6.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+14.5%Week of 31 Jul.
Worst week-14.0%Week of 10 Apr.
Latest week+14.5%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks0
Modest losses6
Sharp losses8
Recent vol6.8%13-week weekly-return volatility.
Base vol10.9%52-week weekly-return volatility.
Up/down split21/30Count of positive and negative weeks in the 52-week window.
Average skew9.2% / -7.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape25/100

Trend, activity pressure, participation, and risk combine to a 25/100 tape read.

 Indicator analysis11/100

Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 0/12.

Activity pressure 0.03; No reversal markers Next-Week ExpectancyNegative 37.80%

Next-week expectancy is negative with a 37.80% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors5/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 60; Small Cap Core rank 87 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment62/100

Weighted news tone is positive across 52 relevant articles.

SS Innovations International Ord Shs (SSII) Technical Analysis: Support, Resistance, Indicators & Moving Averages Insiders50/100

No recent insider transaction evidence is stored.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20263.98 USD14.5%4.27 USD6.25 USD0.37-32.29514.1KOff
24 Jul 20263.48 USD-4.5%4.33 USD6.32 USD-0.00-41.27513.1KOff
17 Jul 20263.64 USD-4.0%4.40 USD6.40 USD-0.30-40.48284.7KOff
10 Jul 20263.79 USD0.3%4.47 USD6.48 USD-0.56-41.74299.4KOff
3 Jul 20263.78 USD13.2%4.53 USD6.55 USD-0.75-41.32403.4KOff
26 Jun 20263.34 USD-3.7%4.61 USD6.62 USD-0.78-48.19216.0KOff
19 Jun 20263.47 USD3.3%4.72 USD6.70 USD-0.62-49.22222.6KOff
12 Jun 20263.36 USD-11.1%4.81 USD6.78 USD-0.50-50.39291.4KOff
5 Jun 20263.78 USD-4.1%4.90 USD6.86 USD-0.31-43.14485.5KOff
29 May 20263.94 USD1.3%5.00 USD6.93 USD-0.28-44.09278.6KOff
22 May 20263.89 USD0.8%5.14 USD6.95 USD-0.21-43.98193.2KOff
15 May 20263.86 USD-0.3%5.31 USD6.98 USD-0.12-45.04278.3KOff
8 May 20263.87 USD-3.0%5.51 USD7.01 USD-0.04-46.48148.0KOff
1 May 20263.99 USD-8.5%5.61 USD7.03 USD-0.06-43.43265.3KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.